Holen Sie sich die Stockscreener-App
189.90
1.35%
-2.60
Handel nachbörslich:
189.45
-0.45
-0.24%
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt AZN?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Astrazeneca Plc Aktie (AZN) Neueste Nachrichten
Dermatomyositis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Octapharma, Argenx, AstraZeneca, Bristol-Myers Squibb Company, Pfizer Inc., Octapharma AG, Corbus Pharma, Holdings - Barchart.com
AstraZeneca (LSE:AZN) Valuation Insights After Recent Price Moves - Kalkine Media
AZN Stock Price and Chart — LSE:AZN - TradingView
AstraZeneca’s DURGA-4 CAR-T Study Puts New Pressure on Multiple Myeloma Rivals - TipRanks
AstraZeneca Advances Pediatric Symbicort Device Study, Supporting Long Term Respiratory Strategy - TipRanks
AstraZeneca (AZN) Refutes Takeover Speculation - GuruFocus
$100 Million AstraZeneca Deal Puts Chinese Biotech Jacobio on Path to Profit - Caixin Global
Abivax denies AstraZeneca takeover rumors reported by French media - Reuters
Abivax Denies La Lettre Report of AstraZeneca Exclusivity - marketscreener.com
Abivax Denies La Lettre Report of AstraZeneca Exclusivity, Bloomberg Reports - marketscreener.com
Van ECK Associates Corp Sells 72,809 Shares of AstraZeneca PLC $AZN - MarketBeat
Eli Lilly Could Rejoin Abivax Bidding If AstraZeneca Misses Deadline - Benzinga
SageView Advisory Group LLC Acquires New Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca (AZN) Enters Exclusive Agreement Boosting Abivax Sha - GuruFocus
BNP Paribas Financial Markets Increases Stock Position in AstraZeneca PLC $AZN - MarketBeat
Capital Research Global Investors Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca in pole position to acquire Abivax - marketscreener.com
Morgan Stanley sees double-digit EPS growth for AstraZeneca PLC (AZN) - MSN
Morgan Stanley Sees Double-Digit EPS Growth for AstraZeneca PLC (AZN) - Yahoo Finance
Franklin Resources Inc. Sells 1,585,664 Shares of AstraZeneca PLC $AZN - MarketBeat
Russell Investments Group Ltd. Has $66.19 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Position Boosted by Bank of Montreal Can - MarketBeat
In Brief: Jacobio/AZ’s JAB-23E73 Reports First Clinical Results For Pan-KRAS Inhibitors - Citeline News & Insights
Zoladex Market Is Booming Worldwide 2026-2033 | AstraZeneca, Pfizer, Ipsen, Novartis - openPR.com
AstraZeneca schedules digital annual general meeting for April 9 - Investing.com South Africa
Joshua Jackson, Gritty urge fans to get checked for cancer early - Stock Titan
AstraZeneca schedules AGM for April 9, 2026 - Investing.com India
Causeway Capital Management LLC Raises Stock Position in AstraZeneca PLC $AZN - MarketBeat
Capital International Investors Sells 6,352,463 Shares of AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Sold by Capital Group Private Client Services Inc. - MarketBeat
Capital International Inc. CA Buys 18,059 Shares of AstraZeneca PLC $AZN - MarketBeat
First Trust Advisors LP Sells 103,714 Shares of AstraZeneca PLC $AZN - MarketBeat
Cresset Asset Management LLC Lowers Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca and Daiichi Sankyo Enter Global Collaboration to Jointly Develop and Commercialize Enhertu - marketscreener.com
AstraZeneca PLC $AZN Shares Sold by Victory Capital Management Inc. - MarketBeat
AstraZeneca (AZN) Achieves Priority Review for Enhertu in Breast Cancer Treatment - GuruFocus
AstraZeneca, Daiichi Sankyo Wins Priority Review for Enhertu for Breast Cancer - marketscreener.com
Brokers Offer Predictions for AstraZeneca FY2026 Earnings - MarketBeat
AstraZeneca (AZN) and Other Drugmakers Watch as Key FDA Official Resigns - GuruFocus
Natixis Advisors LLC Buys 262,465 Shares of AstraZeneca PLC $AZN - MarketBeat
Legacy Capital Group California Inc. Buys New Position in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Shares Purchased by Guardian Capital LP - MarketBeat
AstraZeneca’s AZD5004 Formulation Trial: Early Data Point for Long-Term Pipeline Value - TipRanks
AstraZeneca executives receive vested shares under deferred bonus plan - Investing.com India
AstraZeneca CEO Pascal Soriot receives vested shares under performance plan - Investing.com UK
AstraZeneca awards share grants to CEO and CFO under company incentive plans - Investing.com Nigeria
AstraZeneca (AZN) CEO awarded 101,495 shares on AZPSP vesting - Stock Titan
AstraZeneca (NYSE: AZN) awards deferred bonus shares to leaders - Stock Titan
Jefferies raises AstraZeneca target to 18,000p as analysts flip view on delayed cancer trial - Proactive financial news
Longfellow Investment Management Co. LLC Makes New Investment in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Stock Holdings Raised by Orion Porfolio Solutions LLC - MarketBeat
AstraZeneca Executives Receive Vested Deferred Share Awards - TipRanks
AstraZeneca Grants Long-Term Share Awards to CEO and CFO - TipRanks
The Zacks Analyst Blog Highlights Exxon Mobil, Palantir, AstraZeneca, Gencor Industries and Hour Loop - Yahoo Finance
243,177 Shares in AstraZeneca PLC $AZN Purchased by Foresight Global Investors Inc. - MarketBeat
Top pharma companies racing to launch a weight-loss pill - Reuters
Top Analyst Reports for Exxon Mobil, Palantir & AstraZeneca - Yahoo Finance
Xencor falls on royalty row with AstraZeneca (XNCR:NASDAQ) - Seeking Alpha
Why Astrazeneca (AZN) is a Top Value Stock for the Long-Term - Yahoo Finance
AZN Stock News: Robbins LLP Reminds Investors of the Pending Lea - GuruFocus
HAP Trading LLC Sells 7,267 Shares of AstraZeneca PLC $AZN - MarketBeat
Mengis Capital Management Inc. Boosts Stock Position in AstraZeneca PLC $AZN - MarketBeat
Dimensional Fund Advisors LP Raises Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC $AZN Position Lessened by Teachers Retirement System of The State of Kentucky - MarketBeat
AstraZeneca (AZN) Strengthens Clinical Portfolio and Expands Inv - GuruFocus
AZN SEC FilingsAstraZeneca 10-K, 10-Q, 8-K Forms - Stock Titan
GLP-1 Receptor Agonist Business Analysis Report 2026: Market to Reach $137.4 Billion by 2030 - GlobeNewswire Inc.
CI Investments Inc. Has $18.33 Million Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca Advances Food-Effect Trial for New Cardio-Renal Combo Tablet - TipRanks
AstraZeneca (AZN) adds three fixed-rate US dollar note issues out to 2036 - Stock Titan
AstraZeneca PLC (AZN) Investor Outlook: Evaluating the Healthcare Giant Amidst a -21.01% Potential Downside - DirectorsTalk Interviews
0.53%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):